Jan 14, 2025 · Pharmaceutical giant Eli Lilly (LLY) reduced its full-year revenue outlook, indicating that demand for its diabetes and weight-loss treatments Mounjaro and Zepbound could fall short of elevated...

2 days ago · Eli Lilly (LLY) closed the latest trading day at $804.99, indicating a -0.39% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.92%.

Aug 8, 2024 · Eli Lilly shares popped after the drugmaker reported better-than-expected earnings for the second quarter, boosted by the popularity of its weight-loss drugs. Electronic technology manufacturer...

Jan 19, 2025 · All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly investors haven't had much to celebrate so far in 2025.

11 hours ago · The S&P 500 Index is up 31.86 points or 0.53% today to 6071.17 ... a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock .

22 hours ago · With its 2-star rating, we believe Eli Lilly’s stock is over-valued compared to our long-term fair value estimate. We are maintaining our Eli Lilly fair value estimate at $580.

Oct 3, 2024 · Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. Eli Lilly (LLY) is clearly a force of nature in the biopharma realm. Today, Lilly — the famous...

Shares of Eli Lilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P 500's biggest decliner. The problem is that the drug giant provided...

Nov 6, 2023 · Eli Lilly was a top performer on the S&P 500 index on Monday, while energy plays were among the day's biggest winners and losers.

Mar 30, 2024 · Eli Lilly (LLY) saw the biggest growth in the S&P 500 healthcare index, rising nearly 34% thanks to continued buzz around its weight loss drugs. Sales of its weight loss medicines rose well...